Defective Fasciculata Zone Function as the Mechanism of Glucocorticoid-Remediable Aldosteronism*
Authors:
- Connie K. ChanCCConnie K. Chan
- John R. GillJGJohn R. Gill
- Michael GutkinMGMichael Gutkin
- Lee LetcherLLLee Letcher
- Franco ManteroFMFranco Mantero
- Maria I. NewMNMaria I. New
- 1 November 1990
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 71 (5) , 1151-1157
Abstract
Glucocorticoid-remediable aldosteronism is characterized by unusual sensitivity of aldosterone secretion to ACTH. Suppressibility by glucocorticoid and continued stimulability by exogenous ACTH has provided the basis for diagnosis and treatment of the disorder. A qualitative biochemical abnormality consisting of marked overproduction of the products of the cortisol C-18 oxidation pathway, 18-hydroxycortisol and 18-oxocortisol, has been examined in 10 patients with the disorder and compared to the normal C-18 oxidation products of corticosterone, aldosterone, and 18-hydroxycorticosterone. The technique, based on stable isotope dilution mass fragmentography, measured the tetrahydro urinary metabolites of aldosterone, 18-hydroxycorticosterone, and 18-oxocortisol and unmetabolized 18-hydroxycortisol. All 4 C-18 oxygenated corticosteroids were markedly elevated in the untreated state and showed rapid parallel suppression with low doses of glucocorticoid. The proportional changes in C-18 oxygenated cortisols together with aldosterone and 18-hydroxycorticosterone suggested the mechanism of a common catalytic site of a cytochrome P450 methyl oxidase serving both cortisol and corticosterone substrates. The ACTH-dependent secretion of the C-18 oxidation products of both corticosterone and cortisol in the disorder is attributed to the acquisition of methyl oxidase activity by the fasciculata zone, where there are abundant pools of these precursors.Keywords
This publication has 26 references indexed in Scilit:
- Isolation and identification of 18-hydroxycortisol from the urine of patients with primary aldosteronism.Journal of Biological Chemistry, 1982
- Overproduction of Sodium-Retaining Steroids by the Zona Glomerulosa Is Adrenocorticotropin-Dependent and Mediates Hypertension in Dexamethasone-Suppressible AldosteronismThe Journal of Clinical Endocrinology & Metabolism, 1981
- Biosynthetic and morphological evidence for inhibition of aldosterone production following administration of ACTH to sheepEuropean Journal of Endocrinology, 1980
- Evidence for an Unidentified ACTH-Induced Steroid Hormone Causing HypertensionThe Journal of Clinical Endocrinology & Metabolism, 1976
- Diagnosis and Nomenclature of the Disorders of the Terminal Portion of the Aldosterone Biosynthetic PathwayThe Journal of Clinical Endocrinology & Metabolism, 1976
- HYPERTENSION INCREASED ALDOSTERONE SECRETION AND LOW PLASMA RENIN ACTIVITY RELIEVED BY DEXAMETHASONE1966
- Simultaneous Measurement of Secretory Rates of Aldosterone and 18-HydroxycorticosteroneThe Journal of Clinical Endocrinology & Metabolism, 1965
- An Aldosterone Biosynthetic Defect in a Salt-Losing DisorderThe Journal of Clinical Endocrinology & Metabolism, 1964
- PLASMA AND URINARY CORTICOSTEROIDS IN THE HYPERTENSIVE FORM OF CONGENITAL ADRENAL HYPERPLASIAJournal of Biological Chemistry, 1956
- HISTOLOGICAL, CYTOCHEMICAL AND PHYSIOLOGICAL OBSERVATIONS ON THE REGENERATION OF THE RAT’S ADRENAL GLAND FOLLOWING ENUCLEATION1Endocrinology, 1949